tiprankstipranks
Trending News
More News >
Bonus Biogroup Ltd. (IL:BONS)
:BONS
Israel Market
Advertisement

Bonus Biogroup (BONS) Income Statement

Compare
1 Followers

Bonus Biogroup Income Statement

Last quarter (Q2 2025), Bonus Biogroup's total revenue was 0.00, a decrease of ― from the same quarter last year. In Q2, Bonus Biogroup's net income was -6.33M. See Bonus Biogroup’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
0.00 0.00 0.00 0.00 0.00
Gross Profit
-2.79M -2.76M -3.37M -4.10M -1.61M
Operating Expenses
27.84M 25.58M 37.05M 36.66M 18.38M
Depreciation and Amortization
1.63M 1.65M 2.66M 1.48M 1.07M
EBITDA
-26.20M -28.14M -35.13M -88.01M -18.39M
Operating Income
-27.84M -28.34M -37.05M -64.73M -19.44M
Other Income/Expenses
10.00K -184.00K -1.66M -25.34M -2.58M
Pretax Income
-27.83M -28.53M -38.70M -90.08M -22.02M
Net Income
-27.83M -28.53M -38.70M -90.08M -22.02M
Per Share Metrics
Basic EPS
-0.02 -0.02 -0.06 -0.16 -0.02
Diluted EPS
-0.02 -0.02 -0.06 -0.16 -0.02
Weighted Average Shares Outstanding
1.17B 1.17B 621.08M 579.12M 1.03B
Weighted Average Shares Outstanding (Diluted)
1.17B 1.17B 621.08M 579.12M 1.03B
Currency in ILS

Bonus Biogroup Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis